Overview

Vaginal Infection Study 2

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.
Phase:
Phase 3
Details
Lead Sponsor:
Lumara Health, Inc.
Treatments:
Butoconazole
Clindamycin
Clindamycin palmitate
Clindamycin phosphate